Vaxart had started trials of its oral recombinant tablet vaccine in October last year. It enrolled 96 participants at four centres in the US. Participants included both-the untreated as well as previously vaccinated subjects.
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ZRHLKcD
https://ift.tt/2N1PSvp
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ZRHLKcD
https://ift.tt/2N1PSvp
إرسال تعليق